Pharmaceutical Co. Wins Trademark Case: Injunction Granted, Damages Awarded

The court granted a permanent injunction in favor of the pharmaceutical company, prohibiting the defendants from infringing on the trademark "COLISPAS" and passing off their goods as those of the plaintiff. The court found the plaintiff to be the rightful owner of the trademark, with extensive evidence of its use since 1986. Due to the defendants' unauthorized use of an identical trademark causing confusion, the court ruled in favor of the plaintiff, awarding damages of Rs. 1 lakh and emphasizing the importance of protecting intellectual property rights through legal remedies.

---

---

Issues:
- Infringement of trademark and passing off of goods
- Claim for permanent injunction and damages

Analysis:
The plaintiff, a well-known pharmaceutical company, filed a suit seeking a permanent injunction to restrain the defendants from infringing its trademark "COLISPAS" and passing off their goods as that of the plaintiff. The plaintiff claimed to be the rightful owner of the trademark "COLISPAS," which it had been using since 1986. The plaintiff provided evidence of its extensive and continuous use of the trademark, along with details of sales under the trademark. The plaintiff alleged that the defendants adopted an identical trademark for their medicinal preparations, causing confusion and deception among customers. An ex-parte restraint order was initially granted in favor of the plaintiff, and the defendants failed to contest the claim. The plaintiff's evidence remained unrebutted and unchallenged, establishing the bona fide use of the trademark "COLISPAS" by the plaintiff. The court found that the defendants' use of the identical trademark without approval amounted to infringement and was likely to cause confusion among purchasers.

The court also considered the issue of damages due to the infringement of the plaintiff's trademark and loss of sales and reputation. Citing previous cases, the court highlighted the importance of granting punitive damages to deter wrongdoers from engaging in unlawful activities. Despite the defendants' absence and lack of contesting the suit, the court emphasized the need to award damages to compensate the plaintiff and discourage violations of intellectual property rights. In this case, since the defendants did not appear, the court found it unnecessary to pass a decree for rendition of accounts but awarded damages to the plaintiff based on established facts and legal precedents.

Ultimately, the court decreed in favor of the plaintiff, granting a permanent injunction against the defendants from using the trademark "COLISPAS" or any similar mark for medicinal and pharmaceutical products. The court also awarded damages amounting to Rs. 1 lakh to the plaintiff. The defendant No.3, who settled the dispute with the plaintiff, was not held liable for compensation or damages. The judgment underscored the importance of protecting intellectual property rights and deterring unauthorized use through legal remedies such as injunctions and punitive damages.

---